Inogen, Inc. (INGN) Q2 2025 Earnings Call Transcript
- Inogen, Inc. (NASDAQ:INGN ) Q2 2025 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants Kevin R. M. Smith - President, CEO & Director Lorna Williams - Corporate Participant Michael J.
- 08/08/2025
|
Inogen Stock Gains Following Q2 Earnings Beat, Revenues Up Y/Y
- INGN stock rises as Q2 loss narrows and revenue climbs 4% year over year, driven by strong B2B demand despite DTC and rental declines.
- 08/08/2025
|
Inogen (INGN) Reports Q2 Loss, Beats Revenue Estimates
- Inogen (INGN) came out with a quarterly loss of $0.15 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to a loss of $0.24 per share a year ago.
- 08/07/2025
|
Inogen to Report Second Quarter 2025 Financial Results on August 7, 2025
- GOLETA, Calif.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen to Report Second Quarter 2025 Financial Results on August 7, 2025.
- 07/17/2025
|
Here's Why You Should Add Inogen Stock to Your Portfolio Now
- Expanding product portfolio and high prospects for POC raise optimism for INGN stock.
- 07/16/2025
|
Inogen Introduces Voxi 5 Stationary Oxygen Concentrator: Setting a New Standard in Affordable, Durable Oxygen Therapy
- GOLETA, Calif.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen Introduces Voxi 5 Stationary Oxygen Concentrator: Setting a New Standard in Affordable, Durable Oxygen Therapy.
- 06/23/2025
|
Inogen initiated with a Buy at B. Riley
- B. Riley initiated coverage of Inogen with a Buy rating and $14 price target.
- 06/15/2025
|
Here's Why You Should Add Inogen Stock to Your Portfolio Now
- Expanding product portfolio and high prospects for POC raise optimism for INGN stock.
- 05/28/2025
|
3 Stocks With Upgraded Broker Ratings to Bet on Amid Uncertainties
- Broker upgrades boost URBN, INGN and SWX, with earnings growth and strong Zacks Ranks signaling potential upside despite market volatility.
- 05/27/2025
|
Inogen Upgraded: Analyst Sees Growth, EBITDA Breakthrough
- Needham analyst Mike Matson upgraded Inogen, Inc INGN from Hold to Buy, with a price forecast of $12.
- 05/22/2025
|
What Makes Inogen (INGN) a New Buy Stock
- Inogen (INGN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- 05/16/2025
|
After Plunging -15.69% in 4 Weeks, Here's Why the Trend Might Reverse for Inogen (INGN)
- Inogen (INGN) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
- 05/16/2025
|
INGN Stock Gains Following Q1 Earnings Beat, Revenues Up Y/Y
- Inogen's overall first-quarter 2025 results continue to gain from higher business-to-business sales.
- 05/08/2025
|
Inogen, Inc. (INGN) Q1 2025 Earnings Call Transcript
- Inogen, Inc. (NASDAQ:INGN ) Q1 2025 Earnings Conference Call May 7, 2025 5:00 PM ET Company Participants Ryan Peterson - Investor Relations Kevin Smith - President and CEO Mike Bourque - CFO Conference Call Participants Colin Clark - Stifel Mike Matteson - Needham & Company Margaret Andrew - William Blair Operator Welcome to Inogen's First Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode.
- 05/07/2025
|
Here's What Key Metrics Tell Us About Inogen (INGN) Q1 Earnings
- Although the revenue and EPS for Inogen (INGN) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 05/07/2025
|
Inogen (INGN) Reports Q1 Loss, Tops Revenue Estimates
- Inogen (INGN) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.52. This compares to loss of $0.62 per share a year ago.
- 05/07/2025
|
MedTech Stocks' Earnings to Watch on May 7: COR, QDEL & INGN
- The medical device sector saw steady sales growth in the first quarter of 2025, supported by innovation in AI, wearables, and personalized care. However, earnings gains were more modest as global tariffs, inflationary costs, and supply chain disruptions continued to pressure margins.
- 05/06/2025
|
Here's Why You Should Retain Inogen Stock in Your Portfolio Now
- Expanding product portfolio and high prospects for POC raise optimism for INGN stock.
- 04/16/2025
|
Inogen To Present at 24th Annual Needham Virtual Healthcare Conference
- GOLETA, Calif.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen To Present at 24th Annual Needham Virtual Healthcare Conference.
- 03/20/2025
|
Inogen (INGN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
- Although the revenue and EPS for Inogen (INGN) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 03/13/2025
|
Here's Why You Should Retain Inogen Stock in Your Portfolio Now
- Inogen, Inc. INGN is well-poised for growth in the coming quarters, courtesy of high prospects in the portable oxygen concentrator (POC) space. The optimism, led by solid fourth-quarter 2024 performance and a strong product portfolio, seems justified.
- 03/11/2025
|
A Volatile Share Price Masks Some Of The Progress At Inogen
- Inogen's new management and strategy are yielding results, with better-than-expected 2024 performance and a more stable base from which to keep growing the B2B business. Despite weak DTC sales, strong B2B growth drove better-than-expected sales in Q4, and Inogen likewise beat on margins. Guidance disappointed investors and prompted a 15% drop in the shares, as moderately better revenue guidance was offset by unexpected gross margin deleverage.
- 03/01/2025
|
What's Going On With MedTech Focused Inogen Stock On Wednesday?
- Medical Technology company Inogen Inc INGN reported a fourth-quarter adjusted EPS loss of 24 cents, compared to a loss of 83 cents a year ago, beating the consensus loss of 61 cents.
- 02/26/2025
|
INGN Stock Gains Following Q4 Earnings Beat, Adjusted Gross Margin Up
- Inogen's overall fourth-quarter 2024 results continue to gain from higher business-to-business sales.
- 02/26/2025
|
Inogen, Inc. (INGN) Q4 2024 Earnings Call Transcript
- Inogen, Inc. (NASDAQ:INGN ) Q4 2024 Earnings Conference Call February 25, 2025 5:00 PM ET Company Participants Ryan Peterson – Investor Relations Kevin Smith – President and Chief Executive Officer Mike Bourque – Chief Financial Officer Conference Call Participants Operator Welcome to Inogen's Fourth Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
- 02/25/2025
|
Inogen (INGN) Reports Q4 Loss, Tops Revenue Estimates
- Inogen (INGN) came out with a quarterly loss of $0.41 per share versus the Zacks Consensus Estimate of a loss of $0.57. This compares to loss of $1.14 per share a year ago.
- 02/25/2025
|
Here's Why You Should Add Inogen Stock to Your Portfolio Now
- Expanding product portfolio and high prospects for POC raise optimism for INGN stock.
- 02/06/2025
|
Inogen Announces Appointment of Mira Kirti Sahney to Board of Directors and Retirement of Board Member Tom West
- GOLETA, Calif.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen Announces Appointment of Mira Kirti Sahney to Board of Directors and Retirement of Board Member Tom West.
- 02/03/2025
|
Inogen Stock May Gain on Deal With Yuwell to Expand Global Reach
- INGN and Yuwell collaborate to expand and enhance Inogen's innovation pipeline through R&D collaboration and accelerate the entry of Inogen's brand into the Chinese market.
- 01/28/2025
|
Arab Health 2025｜Yuwell Medical Announces Strategic Investment and Partnership with Inogen in Respiratory Health
- DUBAI, UAE, Jan. 26, 2025 /PRNewswire/ -- On the eve of the Arab Health Exhibition, Yuwell Medical held its 2025 Global Core Partner Conference in Dubai , and announced a strategic investment and partnership with Inogen, a leading U.S. company in respiratory health, highlighting our joint commitment to advancing medical device solutions and deeper collaboration. Speaking at the Yuwell Medical 2025 Global Core Partner Conference, Alex WU, Chairman of Yuwell Medical, stated that as a leading enterprise in China's home medical device industry, Yuwell will rely on internal growth and external mergers and acquisitions to promote internationalisation.
- 01/26/2025
|
Inogen Expands Product Portfolio, Global Reach and Innovation Pipeline Through Strategic Collaboration With Yuwell
- GOLETA, Calif.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen Expands Product Portfolio, Global Reach and Innovation Pipeline Through Strategic Collaboration with Yuwell.
- 01/26/2025
|
Inogen (INGN) Moves to Strong Buy: Rationale Behind the Upgrade
- Inogen (INGN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
- 01/24/2025
|
Inogen Stock Gains Following Solid Preliminary Q4 Revenues
- INGN's revenue growth in the fourth quarter is likely to have been boosted by continued robust adoption of its products.
- 01/15/2025
|
Inogen Announces Preliminary Fourth Quarter and Full Year 2024 Revenue
- GOLETA, Calif.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen Announces Preliminary Fourth Quarter and Full Year 2024 Revenue.
- 01/13/2025
|
Inogen Stock Rises as FDA Clears SIMEOX 200 Airway Clearance Device
- INGN announces FDA clearance for the SIMEOX 200 Airway Clearance Device.
- 12/31/2024
|
Inogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance Device
- GOLETA, Calif.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance Device.
- 12/30/2024
|
Here's Why You Should Retain Inogen Stock in Your Portfolio Now
- Expanding product portfolio and high prospects for POC raise optimism for INGN stock.
- 12/24/2024
|
The Zacks Analyst Blog Intuitive Surgical, Globus Medical, Glaukos, Veracyte and Inogen
- Intuitive Surgical, Globus Medical, Glaukos, Veracyte and Inogen are included in this Analyst Blog.
- 12/12/2024
|
5 Medical Device Stocks That Survived the 2024 Market Volatility
- Here, we discuss five medical device stocks, namely ISRG, GMED, GKOS, VCYT and INGN, which gained in 2024 despite ongoing challenges and provide an attractive investment opportunity for 2025.
- 12/11/2024
|
Inogen (INGN) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
- Inogen (INGN) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
- 11/25/2024
|
INGN Stock Gains Following Q3 Earnings Beat, Adjusted Gross Margin Up
- Inogen's overall third-quarter 2024 results continue to gain from higher business-to-business sales.
- 11/11/2024
|
Inogen, Inc. (INGN) Q3 2024 Earnings Call Transcript
- Call Start: 17:00 January 1, 0000 5:26 PM ET Inogen, Inc. (NASDAQ:INGN ) Q3 2024 Earnings Conference Call November 7, 2024, 5:00 PM ET Company Participants Ryan Peterson - Investor Relations Kevin Smith - President and CEO Mike Bourque - Chief Financial Officer Conference Call Participants Rohin Patel - JPMorgan Mike Matson - Needham Operator Welcome to Inogen's Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
- 11/09/2024
|
Inogen (INGN) Reports Q3 Earnings: What Key Metrics Have to Say
- While the top- and bottom-line numbers for Inogen (INGN) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- 11/08/2024
|
Inogen (INGN) Reports Q3 Loss, Tops Revenue Estimates
- Inogen (INGN) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.51. This compares to loss of $1.97 per share a year ago.
- 11/07/2024
|
Here's Why You Should Retain Inogen Stock in Your Portfolio Now
- Expanding product portfolio and high prospects for POC raise optimism for INGN stock.
- 10/18/2024
|
Inogen to Report Third Quarter 2024 Financial Results on November 7, 2024
- GOLETA, Calif.--(BUSINESS WIRE)---- $INGN #COPD--Inogen to Report Third Quarter 2024 Financial Results on November 7, 2024.
- 10/17/2024
|
Inogen Stock Rises 47% in 6 Months: What's Driving the Rally?
- INGN shows impressive momentum, driven by strong sales growth, an expanding product portfolio and significant advancements in portable oxygen technology.
- 10/04/2024
|
Here's Why You Should Add Inogen Stock to Your Portfolio Now
- Expanding product portfolio and high prospects for POC raise optimism for the INGN stock.
- 09/16/2024
|
Inogen (INGN) Rises 127% Year to Date: What's Driving the Stock?
- Expanding product portfolio and high prospects for POC raise optimism for the Inogen (INGN) stock.
- 08/22/2024
|
Inogen (INGN) Reports Q2 Earnings: What Key Metrics Have to Say
- Although the revenue and EPS for Inogen (INGN) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 08/08/2024
|
Inogen (INGN) Q2 Earnings Beat Estimates, Revenues Rise Y/Y
- Inogen's (INGN) second-quarter 2024 results reflect significant improvement in the top and bottom lines, driven by strong international and domestic business-to-business sales.
- 08/07/2024
|
Inogen, Inc. (INGN) Q2 2024 Earnings Call Transcript
- Inogen, Inc. (NASDAQ:INGN ) Q2 2024 Earnings Conference Call August 6, 2024 5:00 PM ET Company Participants Ryan Peterson - IR Kevin Smith - President and CEO Mike Bourque - CFO Conference Call Participants Lilia-Celine Lozada - JPMorgan James Beer - William Blair Colin Clark - Stifel Michael Matson - Needham & Company Operator Welcome to Inogen's Second Quarter 2024 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded today, August 6, 2024.
- 08/06/2024
|
Inogen (INGN) Reports Q2 Loss, Tops Revenue Estimates
- Inogen (INGN) came out with a quarterly loss of $0.24 per share versus the Zacks Consensus Estimate of a loss of $0.54. This compares to loss of $0.42 per share a year ago.
- 08/06/2024
|
3 Stocks Under $10 With the Potential for Massive Gains
- Investing in small-cap stocks can be a gateway to high returns, mainly when these companies exhibit strong growth fundamentals and strategic market positioning. Here, the focus is on three stocks to buy under $10.
- 07/22/2024
|
3 Reasons to Retain Inogen (INGN) Stock in Your Portfolio Now
- Expanding product portfolio and high prospects for POC raise optimism for Inogen (INGN) stock.
- 07/15/2024
|
Inogen Strengthens Leadership Team with Appointment of New General Counsel and Executive Vice President, Business Development
- GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Kevin P. Smith as General Counsel and Executive Vice President, Business Development, effective July 22, 2024. Mr. Smith joins Inogen from Sirtex Medical, where he served as General Counsel and Executive Vice President, Business Development, since 2018. Mr. Smith brings nearly thirty years of exper.
- 07/03/2024
|
Inogen Announces Publication of Study Demonstrating the Association of Portable Oxygen Therapy with Decreased Mortality and Increased Cost-Effectiveness Ratio
- GOLETA, Calif.--(BUSINESS WIRE)--Inogen Announces Publication of Study.
- 06/03/2024
|
Antea Group UK Joins Inogen Alliance
- NORTHAMPTON, MA / ACCESSWIRE / May 20, 2024 / Inogen AllianceInogen Alliance is pleased to announce the addition of a new Associate company, Antea Group UK. The addition of this new Associate allows us to continue to provide strong EHS and Sustainability support with needed coverage in the United Kingdom. This is a new branch of Antea Group companies which already have multiple Associates across the USA, Brazil, France, Belgium and the Netherlands. In choosing new Associate companies to join the Alliance we have a thorough due diligence process to ensure alignment in values, services and complimentary coverage with our existing companies and approval by the Board of Directors.Antea Group is an international engineering and environmental consulting firm. They specialize in full-service solutions in the fields of environment, health & safety, and sustainability. By combining strategic thinking, multidisciplinary perspectives and technical expertise, they deliver sustainable results for a better future. At Antea Group, subject matter experts are also skilled advisors who fully invest in understanding business drivers and unique culture. Key services include EHS compliance and assurance, environmental due diligence & transactional ESG, corporate mergers & acquisitions, water management, regulatory compliance, EHS management systems, risk management, environmental, contaminated land &geotechnical services, and ecology & arboriculture."We are excited to officially join Inogen Alliance to continue to expand and enhance the global coverage we offer the marketplace. Many of Antea Group UK's clients are multinational and being part of the Alliance allows us to support them with global coverage and local expertise. Having associates around the world who understand the local regulations, their intent and how they may or may not apply to UK client operations is a key differentiator for the firm" Keith Knoke, interim COO, Antea Group UK.More information on Antea Group UK is available here.Inogen Alliance is a global network made up of dozens of independent local businesses and over 6,000 consultants around the world who can help make your project a success. Our Associates collaborate closely to serve multinational corporations, government agencies, and nonprofit organizations, and we share knowledge and industry experience to provide the highest quality service to our clients. If you want to learn more about how you can work with Inogen Alliance, you can explore our Associates or Contact Us. Watch for more News & Blog updates here and follow us on LinkedIn.View additional multimedia and more ESG storytelling from Inogen Alliance on 3blmedia.com.Contact Info:Spokesperson: Inogen AllianceWebsite: https://www.3blmedia.com/profiles/inogen-allianceEmail: info@3blmedia.comSOURCE: Inogen Alliance
- 05/20/2024
|
Inogen (INGN) Q1 Earnings Top Estimates, Revenues Up Y/Y
- Higher business-to-business sales aid Inogen's (INGN) overall first-quarter results.
- 05/09/2024
|
Inogen, Inc. (INGN) Q1 2024 Earnings Call Transcript
- Inogen, Inc. (NASDAQ:INGN ) Q1 2024 Earnings Conference Call May 7, 2024 5:00 PM ET Company Participants Ryan Peterson - Investor Relations Kevin Smith - President and Chief Executive Officer Mike Bourque - Chief Financial Officer Conference Call Participants Colin Clark - Stifel Margaret Kaczor - William Blair Mike Matson - Needham & Company Operator Welcome to Inogen's First Quarter 2024 Earnings Conference Call. At this time all participants are in a listen-only mode.
- 05/07/2024
|
Here's What Key Metrics Tell Us About Inogen (INGN) Q1 Earnings
- While the top- and bottom-line numbers for Inogen (INGN) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- 05/07/2024
|
Inogen Announces First Quarter 2024 Financial Results
- GOLETA, Calif.--(BUSINESS WIRE)--Inogen Announces First Quarter 2024 Financial Results.
- 05/07/2024
|
Inogen to Report First Quarter 2024 Financial Results on May 7, 2024
- GOLETA, Calif.--(BUSINESS WIRE)--Inogen to Report First Quarter 2024 Financial Results on May 7, 2024.
- 04/10/2024
|
Inogen (INGN) Up 26.6% Since Last Earnings Report: Can It Continue?
- Inogen (INGN) reported earnings 30 days ago. What's next for the stock?
- 03/28/2024
|
3 Reasons to Retain Inogen (INGN) Stock in Your Portfolio
- Expanding product portfolio and high prospects for POC raise optimism for Inogen (INGN) stock.
- 03/28/2024
|
Inogen To Present at 23rd Annual Needham Virtual Healthcare Conference
- GOLETA, Calif.--(BUSINESS WIRE)--Inogen To Present at 23rd Annual Needham Virtual Healthcare Conference.
- 03/25/2024
|
Inogen, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that, effective March 4, 2024, the Compensation Committee of Inogen's Board of Directors approved awards of restricted stock units as material inducement to Michael Bourque entering into employment with the company to serve as its Executive Vice President, Chief Financial Officer and Treasurer. The equity awards were.
- 03/07/2024
|
Inogen (INGN) Q4 Earnings Miss Estimates, Gross Margin Improves
- Inogen's (INGN) fourth-quarter earnings and revenues miss their respective consensus estimate. Gross margin expands while the company continues to incur losses at the operating level.
- 02/28/2024
|
Inogen (INGN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
- While the top- and bottom-line numbers for Inogen (INGN) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- 02/27/2024
|
Inogen (INGN) Reports Q4 Loss, Misses Revenue Estimates
- Inogen (INGN) came out with a quarterly loss of $1.14 per share versus the Zacks Consensus Estimate of a loss of $0.65. This compares to loss of $0.57 per share a year ago.
- 02/27/2024
|
Inogen, Inc. (INGN) Q4 2023 Earnings Call Transcript
- Inogen, Inc. (INGN) Q4 2023 Earnings Call Transcript
- 02/27/2024
|
Gear Up for Inogen (INGN) Q4 Earnings: Wall Street Estimates for Key Metrics
- Get a deeper insight into the potential performance of Inogen (INGN) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
- 02/26/2024
|
3 Reasons to Hold Inogen (INGN) Stock in Your Portfolio for Now
- Inogen's (INGN) potential in the POC space and a strong product portfolio raise optimism about the stock.
- 02/23/2024
|
Inogen (INGN) Surges 12.3%: Is This an Indication of Further Gains?
- Inogen (INGN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
- 02/01/2024
|
Inogen to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024
- GOLETA, Calif.--(BUSINESS WIRE)--Inogen to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024.
- 01/30/2024
|
Inogen Names Michael Bourque as New Chief Financial Officer
- GOLETA, Calif.--(BUSINESS WIRE)--Inogen Names Michael Bourque as New Chief Financial Officer.
- 01/24/2024
|
Inogen (INGN) Soars 15.4%: Is Further Upside Left in the Stock?
- Inogen (INGN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
- 01/08/2024
|
3 Reasons to Hold Inogen (INGN) Stock in Your Portfolio
- Inogen's (INGN) potential in the POC space and a strong product portfolio raise optimism about the stock.
- 01/02/2024
|
Inogen: Time To Be Greedy When Others Are Fearful
- Inogen's price performance has been poor this year, but a closer look at the numbers suggests that the market's negativity may be unwarranted. Management is actively taking steps to address the company's issues. I'm issuing a Buy rating, but suggest holding Inogen in a well-diversified portfolio more so than as a single issue.
- 01/01/2024
|
Inogen to Present at Upcoming Investor Conferences in November 2023
- GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management will present at the following investor conferences: Stifel 2023 Healthcare Conference on Wednesday, November 15 at 10:20 a.m. Eastern Time Piper Sandler 35th Annual Healthcare Conference on Wednesday, November 29 at 10:30 a.m. Eastern Time A live webcast and archived recording of each presentation wil.
- 11/09/2023
|
Inogen (INGN) Q3 Earnings Miss Estimates, Revenues Down Y/Y
- Despite higher international business-to-business sales and rental revenues, Inogen's (INGN) overall third-quarter results reflect soft performances.
- 11/08/2023
|
Inogen, Inc. (INGN) Q3 2023 Earnings Call Transcript
- Inogen, Inc. (NASDAQ:INGN ) Q3 2023 Results Conference Call November 7, 2023 5:00 PM ET Company Participants Marissa Bych - IR Gilmartin Group Nabil Shabshab - President and CEO Mike Sergesketter - Interim CFO Conference Call Participants Colin Clark - Stifel Margaret Kaczor - William Blair Rohin Patel - JPMorgan Mike Matson - Needham & Company Operator Greetings, and welcome to the Inogen 2023 Third Quarter Financial Results Conference Call. [Operator Instructions] And as a reminder, this conference is being recorded.
- 11/07/2023
|
Inogen (INGN) Loses -24.08% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
- Inogen (INGN) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
- 10/13/2023
|
3 Reasons to Retain Inogen (INGN) Stock in Your Portfolio
- Inogen's (INGN) potential in the POC space and a strong product portfolio raise optimism about the stock.
- 10/09/2023
|
Inogen (INGN) Completes Buyout Deal to Expand Product Portfolio
- Inogen's (INGN) latest acquisition is expected to expand its global Respiratory Care presence and potentially address a large growing bronchiectasis market.
- 09/19/2023
|
Inogen (INGN) Q2 Earnings Beat Estimates, Revenues Down Y/Y
- Despite higher domestic business-to-business sales and rental revenues, Inogen's (INGN) overall second-quarter results reflect soft performances.
- 08/08/2023
|
Here's What Key Metrics Tell Us About Inogen (INGN) Q2 Earnings
- Although the revenue and EPS for Inogen (INGN) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 08/07/2023
|
Inogen, Inc. (INGN) Q2 2023 Earnings Call Transcript
- Inogen, Inc. (NASDAQ:INGN ) Q2 2023 Earnings Conference Call August 7, 2023 4:30 PM ET Company Participants Agnes Lee - Senior Vice President, Investor Relations and Strategic Planning Nabil Shabshab - President and Chief Executive Officer Kristin Caltrider - Chief Financial Officer Conference Call Participants Brett Krizman - KeyBanc Capital Markets Operator Welcome to Inogen's Second Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded today, August 7, 2023.
- 08/07/2023
|
Inogen (INGN) Reports Q2 Loss, Misses Revenue Estimates
- Inogen (INGN) came out with a quarterly loss of $0.42 per share versus the Zacks Consensus Estimate of a loss of $0.64. This compares to loss of $0.02 per share a year ago.
- 08/07/2023
|
Inogen (INGN) Inks Buyout Agreement to Expand Product Portfolio
- Inogen's (INGN) latest acquisition is expected to leverage its commercial infrastructure and capabilities as well as potentially address a large growing bronchiectasis market.
- 07/17/2023
|
Inogen's (INGN) Preliminary Q2 Revenues Dampened by Lower Sales
- Inogen's (INGN) revenue growth in the second quarter is likely to have been hampered by lower revenues in its business-to-business and direct-to-consumer channels.
- 07/14/2023
|
Inogen: Still Struggling, But Very Cheap - Upgrading To Buy
- Inogen's Q1 2023 results disappointed the market, despite management's confirmation that previously issued FY23E guidance remained unchanged. New product launches, including Rove 6 distribution in Europe, should provide a modest boost to revenue in coming quarters. With a debt-free balance sheet, and ~70% of the company's market capitalization supported by cash and investments, Inogen is a potential acquisition target.
- 07/13/2023
|
Hero or Zero? 7 Speculative Small-Cap Stocks to Make You Rich
- While the traditional approach to market success calls for patiently investing in reliable blue chips, those that want to see more immediate gains may consider small-cap stocks to buy. Here, the point is about accepting massive risk to hopefully realize massive rewards.
- 05/18/2023
|
Inogen to Present at 43rd Annual William Blair Growth Stock Conference
- GOLETA, Calif.--(BUSINESS WIRE)--Inogen to Present at 43rd Annual William Blair Growth Stock Conference.
- 05/15/2023
|
Inogen, Inc. (INGN) Q1 2023 Earnings Call Transcript
- Inogen, Inc. (NASDAQ:INGN ) Q1 2023 Earnings Conference Call May 4, 2023 5:00 PM ET Company Participants Agnes Lee – Senior Vice President-Investor Relations and Strategic Planning Nabil Shabshab – President and Chief Executive Officer Kristin Caltrider – Chief Financial Officer Conference Call Participants Mike Matson – Needham & Co. Matthew Mishan – KeyBanc Operator Welcome to Inogen's First Quarter 2023 Earnings Conference Call. At this time all participants are in a listen-only mode.
- 05/05/2023
|
Inogen (INGN) Q1 Earnings Beat Estimates, Revenues Lag
- Despite higher domestic business-to-business sales and rental revenues, Inogen's (INGN) overall first-quarter results reflect soft performances.
- 05/05/2023
|
Here's What Key Metrics Tell Us About Inogen (INGN) Q1 Earnings
- While the top- and bottom-line numbers for Inogen (INGN) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- 05/04/2023
|
Inogen (INGN) Reports Q1 Loss, Lags Revenue Estimates
- Inogen (INGN) came out with a quarterly loss of $0.63 per share versus the Zacks Consensus Estimate of a loss of $0.77. This compares to loss of $0.38 per share a year ago.
- 05/04/2023
|
Inogen to Present at 22nd Annual Needham Virtual Healthcare Conference
- GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management will participate in a virtual fireside chat at the 22nd Annual Needham Virtual Healthcare Conference on Wednesday, April 19, 2023 at 12:45 p.m. Eastern Time.
- 04/04/2023
|
Here's Why You Should Retain Inogen (INGN) Stock for Now
- Investors continue to be optimistic about Inogen (INGN) on its potential in the POC space and a strong product portfolio.
- 03/27/2023
|
Strength Seen in Inogen (INGN): Can Its 5.0% Jump Turn into More Strength?
- Inogen (INGN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
- 03/22/2023
|
Inogen (INGN) Q4 Earnings Beat Estimates, Revenues Lag
- Inogen's (INGN) fourth-quarter results benefit from higher revenues in its domestic business-to-business sales channel.
- 02/24/2023
|
Inogen Inc. (INGN) Q4 2022 Earnings Call Transcript
- Inogen Inc. (NASDAQ:INGN ) Q4 2022 Results Conference Call February 23, 2023 5:00 PM ET Company Participants Agnes Lee - SVP of IR and Strategic Planning Nabil Shabshab - President and CEO Kristin Caltrider - CFO Conference Call Participants Matthew Blackman - Stifel Michael Matson - Needham & Company Operator Greetings. Welcome to the Inogen 2022 Fourth Quarter Financial Results.
- 02/23/2023
|
3 Reasons to Retain Inogen (INGN) Stock in Your Portfolio
- Investors continue to be optimistic about Inogen (INGN) on its potential in the POC space and a strong product portfolio.
- 02/22/2023
|
Inogen (INGN) Announces Solid Preliminary Q4 Revenues
- Inogen's (INGN) revenue growth in the fourth quarter is likely to have been boosted by continued strength in its product sales.
- 01/13/2023
|
3 Reasons to Retain Inogen (INGN) Stock in Your Portfolio
- Investors continue to be optimistic about Inogen (INGN) on its potential in the POC space and a strong product portfolio.
- 12/27/2022
|
3 Beaten-Down MedTech Stocks Poised for a Turnaround in 2023
- Here are some dirt-cheap MedTech value stocks - DYNT, INGN, AVNS - which are expected to provide long-term gains.
- 12/09/2022
|
Inogen (INGN) Q3 Earnings and Revenues Beat Estimates
- Inogen's (INGN) third-quarter results benefit from higher revenues in its domestic business-to-business sales channel.
- 11/03/2022
|
Inogen, Inc. (INGN) Q3 2022 Earnings Call Transcript
- Inogen, Inc. (NASDAQ:INGN ) Q3 2022 Results Conference Call November 2, 2022 8:00 AM ET Company Participants Agnes Lee - SVP of IR and Strategic Planning Nabil Shabshab - President and CEO Kristin Caltrider - CFO Conference Call Participants Mathew Blackman - Stifel Mike Matson - Needham & Company Margaret Kaczor - William Blair Matt Mishan - KeyBanc Operator Welcome to Inogen's Third Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode.
- 11/02/2022
|
3 Reasons to Add Inogen (INGN) Stock to Your Portfolio Now
- Investors continue to be optimistic about Inogen (INGN) on its potential in the POC space and a strong product portfolio.
- 10/17/2022
|
Inogen to Announce Third Quarter 2022 Financial Results on November 2, 2022
- GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will issue third quarter 2022 financial results before the market opens on Wednesday, November 2, 2022. On the same day, the Company will host a conference call beginning at 5:30 am PT / 8:30 am ET. Individuals interested in listening to the conference call may do so by dialing: US domestic callers (877) 841-3961 N
- 10/05/2022
|
Inogen: Little Breathing Room
- Inogen has been a long-term growth story which has seen real execution challenges in recent years. Current supply chain woes make up for a tough margin picture, yet operational issues have been seen for a couple of years now.
- 09/15/2022
|
3 Reasons to Hold Inogen (INGN) Stock in Your Portfolio
- Investors continue to be optimistic about Inogen (INGN) on its potential in the POC space and a strong product portfolio.
- 09/13/2022
|
Inogen: Structural, Supply Chain Headwinds Remain
- Inogen came in with a mixed set of numbers, however, longer-term structural headwinds remain in situ. The hold rating on INGN remains intact following Q2 earnings, and I've noticed similar themed risks looking ahead.
- 09/13/2022
|
Inogen (INGN) Q2 Earnings and Revenues Beat Estimates
- Inogen's (INGN) second-quarter results benefit from higher revenues in its international business-to-business sales channel.
- 08/08/2022
|
Inogen, Inc. (INGN) CEO Nabil Shabshab on Q2 2022 Results - Earnings Call Transcript
- Inogen, Inc. (NASDAQ:INGN ) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants Agnes Lee - SVP of IR and Strategic Planning Nabil Shabshab - President and CEO Kristin Caltrider - CFO Conference Call Participants Brett Fishbin - KeyBanc Maggie Boeye - William Blair Rohin Patel - JPMorgan Mike Matson - Needham & Company Operator Welcome to the Inogen's Second Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode.
- 08/07/2022
|
Inogen (INGN) Surges 5.1%: Is This an Indication of Further Gains?
- Inogen (INGN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
- 08/01/2022
|
Earnings Preview: Inogen (INGN) Q2 Earnings Expected to Decline
- Inogen (INGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 07/28/2022
|
Inogen to Announce Second Quarter 2022 Financial Results on August 4, 2022
- GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release second quarter 2022 financial results after market close on Thursday, August 4, 2022. The Company will host a corresponding conference call beginning at 2:00 pm PT/5:00 pm ET. Individuals interested in listening to the conference call may do so by dialing: US domestic callers (877) 841-3961 Internation
- 07/07/2022
|
Here's Why You Should Hold on to Inogen (INGN) Stock For Now
- Investors continue to be optimistic about Inogen (INGN) on its potential in the POC space and a strong product portfolio.
- 06/22/2022
|
Inogen's (INGN) CEO Nabil Shabshab on Q1 2022 Results - Earnings Call Transcript
- Inogen, Inc. (NASDAQ:INGN ) Q1 2022 Earnings Conference Call May 5, 2022 5:00 PM ET Company Participants Jason Somer - General Counsel Nabil Shabshab - President & CEO Kristin Caltrider - CFO Conference Call Participants Lilia-Celine Lozada - J.P. Morgan Matthew Mishan - KeyBanc Capital Markets Mike Matson - Needham & Company Operator Welcome to Inogen's First Quarter 2022 Earnings Conference Call.
- 05/07/2022
|
Inogen (INGN) Reports Q1 Loss, Tops Revenue Estimates
- Inogen (INGN) delivered earnings and revenue surprises of 20.83% and 5.09%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- 05/05/2022
|
Inogen to Announce First Quarter 2022 Financial Results on May 5, 2022
- GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release first quarter 2022 financial results after market close on Thursday, May 5, 2022. The Company will host a corresponding conference call beginning at 2:00pm PT/5:00pm ET. Individuals interested in listening to the conference call may do so by dialing (877) 841-3961 for domestic callers or (201) 689-8589
- 04/14/2022
|
Hammered By Supply Issues, Inogen Could Be A 2023 Comeback Story
- Supply chain issues have hit Inogen hard, undermining the company's ability to ship to demand and driving some share loss despite healthy underlying demand trends.
- 03/31/2022
|
Here's Why You Should Hold on to Inogen (INGN) Stock Now
- Inogen (INGN) continues to benefit from strength in the direct-to-customer business model. However, rising costs remain a woe.
- 03/29/2022
|
Inogen (INGN) Stock Surges 16.5% Despite Q4 Earnings Miss
- Inogen's (INGN) fourth-quarter results benefit from higher revenues across the majority of its geographical segments.
- 03/01/2022
|
Inogen (INGN) Reports Q4 Loss, Misses Revenue Estimates
- Inogen (INGN) delivered earnings and revenue surprises of -36.49% and 0.04%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
- 02/24/2022
|
Inogen, Inc. (INGN) CEO Nabil Shabshab on Q4 2021 Results - Earnings Call Transcript
- Inogen, Inc. (INGN) CEO Nabil Shabshab on Q4 2021 Results - Earnings Call Transcript
- 02/24/2022
|
Inogen to Announce Fourth Quarter 2021 Financial Results on February 24, 2022
- GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release fourth quarter 2021 financial results after market close on Thursday, February 24, 2022. The Company will host a corresponding conference call beginning at 2:00pm PT/5:00pm ET. Individuals interested in listening to the conference call may do so by dialing (877) 841-3961 for domestic callers or (201) 6
- 01/26/2022
|
Inogen's (INGN) Preliminary Q4 Revenues Solid Amid Challenges
- Inogen's (INGN) revenue growth in the fourth quarter is likely to have been boosted by solid product sales despite supply chain constraints.
- 01/12/2022
|
Inogen, Inc. (INGN) CEO Nabil Shabshab on Q3 2021 Results - Earnings Call Transcript
- Inogen, Inc. (INGN) CEO Nabil Shabshab on Q3 2021 Results - Earnings Call Transcript
- 11/06/2021
|
Inogen (INGN) Earnings and Revenues Surpass Estimates in Q3
- Inogen's (INGN) third-quarter results benefit from higher revenues across its segments.
- 11/05/2021
|
Inogen (INGN) Q3 Earnings and Revenues Surpass Estimates
- Inogen (INGN) delivered earnings and revenue surprises of 282.76% and 9.04%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
- 11/04/2021
|
Inogen to Announce Third Quarter 2021 Financial Results on November 4, 2021
- GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release third quarter 2021 financial results after market close on Thursday, November 4, 2021. The Company will host a corresponding conference call beginning at 2:00pm PT/5:00pm ET. Individuals interested in listening to the conference call may do so by dialing (877) 841-3961 for domestic callers or (201) 689
- 10/13/2021
|
Inogen Appoints Stanislav Glezer as Chief Technology Officer
- GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), (“Inogen” or “the Company”), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that Stanislav Glezer, MD has been appointed to the role of Chief Technology Officer responsible for R&D and Engineering, Medical Affairs, and Regulatory Affairs. Mr. Glezer will remain an Executive Vice President of the Company. Dr. Glezer joined Inogen in June 2021 as Executive Vice
- 10/12/2021
|
Here's Why You Should Retain Inogen (INGN) Stock For Now
- Investors continue to be optimistic about Inogen (INGN) on its potential in the POC space and a strong product portfolio.
- 09/21/2021
|
Inogen (INGN) Stock Loses 26.7% In Spite of Q2 Earnings Beat
- Inogen's (INGN) second-quarter results benefit from higher revenues across its segments.
- 08/06/2021
|
Inogen Stock Plunges As Supply Chain Constraints Pile Up To Hit 2H FY21; Analysts Downgrade Stock
- Inogen Inc (NASDAQ: INGN) reported Q2 revenue of $101.6 million, +41.7% Y/Y, beating the consensus of $88.75 million. The sales growth was driven primarily due to strong consumer demand, improved average selling prices in all channels, and reduced COVID-19 pandemic-related impacts.
- 08/05/2021
|
Inogen stock heads for record plunge as chip shortage to hurt sales, margins for another year
- Shares of Inogen Inc. plunged to pace all decliners Thursday, after the portable oxygen container (POC) company reported a surprise second-quarter profit and a big revenue beat, but warned that the semiconductor shortage will likely keep hurting sales and margins for the next year.
- 08/05/2021
|
Inogen, Inc. (INGN) CEO Nabil Shabshab on Q2 2021 Results - Earnings Call Transcript
- Inogen, Inc. (INGN) CEO Nabil Shabshab on Q2 2021 Results - Earnings Call Transcript
- 08/04/2021
|
Inogen (INGN) Q2 Earnings and Revenues Beat Estimates
- Inogen (INGN) delivered earnings and revenue surprises of 269.23% and 15.22%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
- 08/04/2021
|
Inogen to Announce Second Quarter 2021 Financial Results on August 4, 2021
- GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release second quarter 2021 financial results after market close on Wednesday, August 4, 2021. The Company will host a corresponding conference call beginning at 1:30pm PT/4:30pm ET. Individuals interested in listening to the conference call may do so by dialing (877) 841-3961 for domestic callers or (201) 689
- 07/14/2021
|
Top Ranked Momentum Stocks to Buy for June 29th
- Top Ranked Momentum Stocks to Buy for June 29th
- 06/29/2021
|
Here's Why You Should Add Inogen (INGN) to Your Portfolio
- Investors continue to be optimistic about Inogen (INGN) on its direct-to-customer business model and a strong product portfolio.
- 06/23/2021
|
Inogen Announces Appointment of General Counsel
- GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that its Board of Directors has appointed Jason Somer as Inogen's Executive Vice President and General Counsel and Secretary, effective July 12, 2021. Nabil Shabshab, Inogen's Chief Executive Officer, said, “On behalf of the Board of Directors, I would like to congratulate Jason on this appointment as I believe that
- 06/21/2021
|
Inogen Strengthens Board of Directors with Addition of Elizabeth Mora
- GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that Elizabeth (Beth) Mora has been appointed to its Board of Directors, effective May 24, 2021. In addition, Ms. Mora was appointed as a member of the Board's Audit Committee. She will serve as a Class I director, with a term expiring at the annual meeting of stockholders to be held in 2024. Ms. Mora fills the vacan
- 05/24/2021
|
Inogen (INGN) Q1 Loss Narrower Than Expected, Revenues Beat
- Inogen (INGN) gains traction from revenue growth within its Rental segment in Q1.
- 05/05/2021
|
Inogen, Inc. (INGN) CEO Nabil Shabshab on Q1 2021 Results - Earnings Call Transcript
- Inogen, Inc. (INGN) CEO Nabil Shabshab on Q1 2021 Results - Earnings Call Transcript
- 05/04/2021
|
4 Medical Products Stocks Set to Beat This Earnings Season
- Rebound in base sales make us optimistic about OMI, INGN, XRAY and CNTG's results this time around.
- 05/04/2021
|
Inogen's Earnings Outlook
- Inogen (NASDAQ:INGN) unveils its next round of earnings this Tuesday, May 04. Get prepared with Benzinga's ultimate preview for Inogen's Q1 earnings.
- 05/03/2021
|
Inogen to Announce First Quarter 2021 Financial Results on May 4th, 2021
- GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release first quarter 2021 financial results after market close on Tuesday, May 4th, 2021. The Company will host a corresponding conference call beginning at 1:30pm PT/4:30pm ET. Individuals interested in listening to the conference call may do so by dialing (877) 841-3961 for domestic callers or (201) 689-858
- 04/19/2021
|
Inogen Announces Appointment of Chief Commercial Officer, Transition of Certain Officers, and Preliminary, Unaudited First Quarter 2021 Revenue Range
- GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that its Board of Directors has appointed George Parr as Inogen's Executive Vice President and Chief Commercial Officer, effective April 12, 2021. On April 2, 2021 and April 5, 2021, respectively, Byron Myers, Executive Vice President, Marketing, and Arron Retterer, Executive Vice President, Sales, announced that the
- 04/07/2021
|
Inogen Announces Participation in the KeyBanc Life Sciences & MedTech Investor Forum
- GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company's management will be participating in the KeyBanc Life Sciences & MedTech Investor Forum. Inogen's President and CEO, Nabil Shabshab, and CFO, Alison Bauerlein, are scheduled to present on Tuesday, March 23rd, 2021 at 3:30 p.m. ET. Interested parties can access the webcast from the News / Events
- 03/12/2021
|
Inogen (INGN) Q4 Earnings and Revenues Surpass Estimates
- Inogen's (INGN) fourth-quarter results benefit from higher rental revenues and strength in business-to-business revenues.
- 02/25/2021
|
Inogen's (INGN) CEO Nabil Shabshab on Q4 2020 Results - Earnings Call Transcript
- Inogen's (INGN) CEO Nabil Shabshab on Q4 2020 Results - Earnings Call Transcript
- 02/24/2021
|
Inogen (INGN) Reports Q4 Loss, Tops Revenue Estimates
- Inogen (INGN) delivered earnings and revenue surprises of 17.86% and 6.92%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
- 02/24/2021
|
Recap: Inogen Q4 Earnings
- Shares of Inogen (NASDAQ:INGN) fell in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share decreased 483.33% year over year to ($0.23), which beat the estimate of ($0.26).
- 02/24/2021
|
Inogen Announces Fourth Quarter 2020 Financial Results
- GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three- and twelve-month periods ended December 31, 2020. Fourth Quarter 2020 Highlights Total revenue of $74.0 million, down 6.3% from the same period in 2019, primarily due to the impacts of the COVID-19 pandemic Domestic business-to-business sales of $24.2 million, up 17.9% from the same pe
- 02/24/2021
|
Earnings Outlook For Inogen
- Inogen (NASDAQ:INGN) announces its next round of earnings this Wednesday, February 24. Here is Benzinga's everything-that-matters guide for this Wednesday's Q4 earnings announcement.
- 02/23/2021
|
Inogen Strengthens Board of Directors with Addition of Kristen Miranda
- GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that Kristen Miranda has been appointed to its Board of Directors, effective March 1, 2021. In addition, Ms. Miranda was appointed to the Board's Compensation Committee. She will serve as a Class I director, with a term expiring at the annual meeting of stockholders to be held in 2021. Ms. Miranda fills the vacancy o
- 02/16/2021
|
Inogen to Announce Fourth Quarter and Year End 2020 Financial Results on February 24th, 2021
- GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release fourth quarter and year end 2020 financial results after market close on Wednesday, February 24th, 2021. The Company will host a corresponding conference call beginning at 1:30pm PT/4:30pm ET. Individuals interested in listening to the conference call may do so by dialing (877) 841-3961 for domestic ca
- 02/09/2021
|
Inogen Announces CEO Transition
- GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that its Board of Directors has appointed Nabil Shabshab as Inogen's President and Chief Executive Officer (“CEO”), effective February 8, 2021. In addition, Mr. Shabshab was appointed to the Board of Directors, effective February 8, 2021. Mr. Shabshab will succeed Scott Wilkinson, who is retiring as President, CEO, a
- 01/27/2021
|
Inogen Announces Participation in the 39th Annual J.P. Morgan Healthcare Conference
- GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company's management will be participating in the 39th Annual J.P. Morgan Healthcare Conference. Inogen's President and CEO, Scott Wilkinson, and CFO, Alison Bauerlein, are scheduled to present on Tuesday, January 12th, 2021 at 5:20 p.m. EST. Interested parties can access the live audio webcast from the News
- 12/18/2020
|
Inogen Announces Participation in the Stifel 2020 Virtual Healthcare Conference
- GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company's management will be participating in the Stifel 2020 Virtual Healthcare Conference. Inogen's President and CEO, Scott Wilkinson, and CFO, Alison Bauerlein, are scheduled to present on Tuesday, November 17th, 2020 at 4:00 p.m. EST at the Stifel 2020 Virtual Healthcare Conference. Interested parties c
- 11/10/2020
|
Inogen Inc. (INGN) CEO Scott Wilkinson on Q3 2020 Results - Earnings Call Transcript
- Inogen Inc. (INGN) CEO Scott Wilkinson on Q3 2020 Results - Earnings Call Transcript
- 11/04/2020
|
Inogen Inc (INGN) CEO Scott Wilkinson on Q2 2020 Results - Quick Version Earnings Call Transcript
- Inogen Inc (INGN) CEO Scott Wilkinson on Q2 2020 Results - Quick Version Earnings Call Transcript
- 11/04/2020
|
Monero (XMR) Developers Unveil Performance Enhancing ‘Oxygen Orion’ Update | BTCMANAGER
- Privacy-centric cryptocurrency Monero (XMR) has gone live with a new version of its node software. Monero Goes-Live with ‘Oxygen Orion’ One of the most well-known privacy-centric digital currencies today, Monero recently officially unveiled a new version of its node software called ‘Oxygen Orion.’ Notably, the latest update to the node…
- 10/18/2020
|
Inogen to Announce Third Quarter 2020 Financial Results on Wednesday, November 4th, 2020
- Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it
- 10/14/2020
|
Holistic Overview Of Chemical Oxygen Demand Meters Market based on rising trends to 2029
- Pune, Maharashtra, India, September 22 2020 (Wiredrelease) Prudour Pvt. Ltd –:The “Global Chemical Oxygen Demand Meters market research report | eTurboNews | Trends | Travel News |
- 09/22/2020
|
Inogen: Running Out Of Breath
- With the current stay at home orders for seniors, the value proposition of Inogen’s products greatly diminishes.
- 09/08/2020
|
Has Inogen (NASDAQ:INGN) Got What It Takes To Become A Multi-Bagger?
- To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'd want to...
- 08/06/2020
|
Global Oxygen Concentrators Market Analysis 2015-2030 - ResearchAndMarkets.com
|
Inogen's (INGN) Q2 Earnings Beat Estimates, Revenues Miss
- Inogen (INGN) saw growth in revenues within its Rental segment in Q2.
- 08/05/2020
|
Inogen Inc (INGN) Q2 2020 Earnings Call Transcript
- Joining me from Inogen is CEO, Scott Wilkinson and CFO and Co-Founder Ali Bauerlein. Earlier today, Inogen released financial results for the second quarter of 2020. As a reminder, the information presented today will include forward-looking statements, including without limitation, statements about our growth prospects and strategy for 2020 and beyond, our ability to create shareholder value by driving awareness of our products, expectations regarding international sales and tender activity, sales expectations in our domestic sales channels, including expectations related to our rental channel, hiring expectations and expectations regarding our sales and marketing roles, expectations regarding reimbursement and regulatory changes and the impact of COVID-19 public health emergency or PHE on our business and demand for our products.
- 08/05/2020
|
Inogen (INGN) Q2 Earnings Beat Estimates
- Inogen (INGN) delivered earnings and revenue surprises of 250.00% and -10.08%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
- 08/04/2020
|
Recap: Inogen Q2 Earnings
- Shares of Inogen (NASDAQ:INGN) were flat in after-market trading after the company reported Q2 results.Quarterly Results Earnings per share were down 73.33% over the past year to $0.12, which beat the estimate of ($0.06).Revenue of $71,691,000 declined by 29.06% from the same period last year, which missed the estimate of $79,960,000.Guidance Earnings guidance hasn't been issued by the company for now.Inogen hasn't issued any revenue guidance for the time being.Details Of The Call Date: Aug 04, 2020View more earnings on INGNTime: 04:30 PMET Webcast URL: https://investor.inogen.com/news-events/ir-calendarRecent Stock Performance Company's 52-week high was at $76.89Company's 52-week low was at $29.28Price action over last quarter: down 22.44%Company Profile Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. The majority of rental revenue comes from Medicare service reimbursement programs. Internationally, Inogen sells its products through distributors or large gas companies and home oxygen providers. Inogen generates the majority of its revenue in the United States.See more from Benzinga * Stocks That Hit 52-Week Lows On Monday * Benzinga's Top Upgrades, Downgrades For June 11, 2020(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
- 08/04/2020
|
Inogen Announces Second Quarter 2020 Financial Results
- Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three-month period ended June 30, 2020.
- 08/04/2020
|
Inogen: Breathing For Air
- Inogen has been a real boom and bust story in terms of its stock price in recent years. The company has seen a steady growth trajectory come to a standstill, with real pressure seen on margins.
- 07/29/2020
|
Earnings Preview: Inogen (INGN) Q2 Earnings Expected to Decline
- Inogen (INGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 07/28/2020
|
Inogen: Backdoor Bet On Travel
- Small-cap medical device company trading at attractive valuations. Leader in portable oxygen concentrators, offering COPD patients mobility.
- 07/27/2020
|
COVID-19 Impact and Recovery Analysis - Global Medical Oxygen Concentrators Market 2020-2024 | Evolving Opportunities with Chart Industries Inc. and Drive DeVilbiss Healthcare Ltd. | Technavio
- The Global Medical Oxygen Concentrators Market will grow by USD 1.14 bn during 2020-2024
- 07/14/2020
|
Wells Fargo & Company MN Purchases 5,997 Shares of Inogen Inc (NASDAQ:INGN)
- Wells Fargo & Company MN raised its position in shares of Inogen Inc (NASDAQ:INGN) by 16.7% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 41,937 shares of the medical technology company’s stock after acquiring an additional 5,997 shares during the period. Wells Fargo & Company MN’s holdings in Inogen were worth $2,168,000 at […]
- 07/11/2020
|
Inogen to Announce Second Quarter 2020 Financial Results on Tuesday, August 4th, 2020
- Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release second quarter 2020 financial results after market close on Tuesday, August 4th, 2020. The Company will host a corresponding conference call beginning at 1:30pm PT/4:30pm ET.
- 07/07/2020
|
Inogen to Announce Second Quarter 2020 Financial Results on Tuesday, August 4th, 2020
- Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it
- 07/07/2020
|
Morgan Stanley Has $10.47 Million Stake in Inogen Inc (NASDAQ:INGN)
- Morgan Stanley raised its stake in Inogen Inc (NASDAQ:INGN) by 99.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 202,676 shares of the medical technology company’s stock after buying an additional 100,831 shares during the quarter. Morgan Stanley owned 0.92% of Inogen […]
- 07/06/2020
|
Inogen Inc (INGN): Are Hedge Funds Right About This Stock?
- We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, professional investors have to conduct complex analyses, spend many resources and use tools that are not […]
- 07/05/2020
|
Inogen Inc (NASDAQ:INGN) Shares Bought by Janus Henderson Group PLC
- Janus Henderson Group PLC raised its stake in Inogen Inc (NASDAQ:INGN) by 5.8% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 13,499 shares of the medical technology company’s stock after acquiring an additional 734 shares during the quarter. Janus Henderson Group PLC’s […]
- 06/24/2020
|
COVID-19 Impact and Recovery Analysis - Global Medical Oxygen Concentrators Market 2020-2024 | Evolving Opportunities with Chart Industries Inc. and Drive DeVilbiss Healthcare Ltd. | Technavio
- The Global Medical Oxygen Concentrators Market will grow by $1.14 bn during 2020-2024
- 06/19/2020
|
State Street Corp Buys 23,149 Shares of Inogen Inc (NASDAQ:INGN)
- State Street Corp boosted its stake in Inogen Inc (NASDAQ:INGN) by 3.5% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 683,209 shares of the medical technology company’s stock after purchasing an additional 23,149 shares during the period. State Street Corp […]
- 06/10/2020
|
Inogen Reports CEO Scott Wilkinson To Retire
|
Inogen CEO Announces Intent to Retire Before End of 2021; Inogen Commences Search for Successor
- Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that in connection with Inogen’s succession planning activities, Scott Wilkinson, the Company’s Chief Executive Officer and President, has informed the Company’s Board of Directors (the "Board") that he intends to retire as Chief Executive Officer and President, and as a member of the Board, in each case before the end of 2021. In order to ensure an orderly transition, Mr. Wilkinson intends to remain in his current position until the appointment of his successor and will assist the Board in the search for his successor and help with transition as necessary. Inogen has initiated a process to identify a successor for Mr. Wilkinson and intends to engage an executive search firm to support the search.
- 06/09/2020
|
Edited Transcript of INGN earnings conference call or presentation 5-May-20 8:30pm GMT
- Q1 2020 Inogen Inc Earnings Call
- 06/09/2020
|
Inogen CEO Announces Intent to Retire Before End of 2021; Inogen Commences Search for Successor
- Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced th
- 06/09/2020
|
Why Is Inogen (INGN) Down 2.9% Since Last Earnings Report?
- Inogen (INGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- 06/04/2020
|
Inogen Announces Participation in the 40th Annual William Blair Growth Stock Conference
- Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the 40th Annual William Blair Growth Stock Conference.
- 06/03/2020
|
31 Stocks Moving in Wednesday's Pre-Market Session
|
Inogen Announces Participation in the 40th Annual William Blair Growth Stock Conference
- Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced th
- 06/03/2020
|
SVB Leerink Maintains Market Perform on Inogen, Lowers Price Target to $42
|
Here's Why You Should Retain Inogen in Your Portfolio Now
- Investor confidence is high in Inogen (INGN) stock, thanks to solid prospects.
- 05/28/2020
|
Medical Oxygen Concentrators & Oxygen Cylinders Market Report 2020 - ResearchAndMarkets.com
|
New challenger bank caters to freelancers, gig workers
- Oxygen helps customers obtain business licenses and separate their personal and business lives. Its says its services will be in demand as the pandemic accelerates a shift away from traditional jobs.
- 05/15/2020
|
Oxygen Launches Digital Banking Platform for Freelancers and Small Businesses, Joins Visa’s Fast Track Program
- Oxygen today announced the launch of a new digital banking solution specifically designed to meet the unique needs of freelancers and digital natives.
- 05/14/2020
|
Were Hedge Funds Right About Inogen Inc (INGN)?
- We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P; 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
- 05/11/2020
|
66 Biggest Movers From Yesterday
|
Mid-Afternoon Market Update: NASDAQ Jumps Over 100 Points; Nautilus Shares Plummet
|
58 Stocks Moving In Wednesday's Mid-Day Session
|
Mid-Day Market Update: Crude Oil Down 6%; Cars.com Shares Jump On Upbeat Q1 Results
|
SVB Leerink Maintains Market Perform on Inogen, Lowers Price Target of $56
|
Inogen's (INGN) Q1 Earnings and Revenues Beat Estimates
- Inogen (INGN) reported growth in business-to-business international and domestic revenues in Q1.
- 05/06/2020
|
'Concerned and confused' about the future, young adults try to navigate through the coronavirus crisis
- From a drop in income to the inability to pay bills, young adults are facing obstacles they weren't necessarily expecting.
- 05/06/2020
|
Mid-Morning Market Update: Markets Mixed; General Motors Beats Q1 Views
|
Needham Maintains Buy on Inogen, Lowers Price Target to $75
|
Edited Transcript of INGN earnings conference call or presentation 5-May-20 8:30pm GMT
- Q1 2020 Inogen Inc Earnings Call
- 05/06/2020
|
Inogen, Inc. (INGN) CEO Scott Wilkinson on Q1 2020 Results - Earnings Call Transcript
- Inogen, Inc. (NASDAQ:INGN) Q1 2020 Results Conference Call May 05, 2020 04:30 PM ET Company Participants Matt Bacso - IR Scott Wilkinson - CEO Ali Bauerlein - C
- 05/06/2020
|
Inogen Inc (INGN) Q1 2020 Earnings Call Transcript
- Joining me from Inogen is CEO, Scott Wilkinson; and CFO and Co-Founder, Ali Bauerlein. Earlier today, Inogen released financial results for the first quarter of 2020. As a reminder, the information presented today will include forward-looking statements, including without limitation statements about our growth prospects and strategy for 2020 and expectations regarding international sales and tender activity, the impact of COVID-19 public health emergency or PHE on our business and demand for our products and expectations regarding related reimbursement and regulatory changes.
- 05/06/2020
|
Inogen Sees Relative Strength Rating Improve To 74
|
Inogen (INGN) Reports Q1 Loss, Tops Revenue Estimates
- Inogen (INGN) delivered earnings and revenue surprises of 36.36% and 6.69%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
- 05/05/2020
|
Inogen Announces First Quarter 2020 Financial Results
- Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three-month period ended March 31, 2020.
- 05/05/2020
|
Inogen Q1 EPS $(0.070) Beats $(0.100) Estimate, Sales $88.500M Beat $82.330M Estimate
|
Inogen Trying To Close In On Key Technical Measure
|
Is Inogen, Inc. (NASDAQ:INGN) Investing Your Capital Efficiently?
- Today we'll look at Inogen, Inc. (NASDAQ:INGN) and reflect on its potential as an investment. Specifically, we're...
- 05/01/2020
|
Covid-19 Hurting Sales of Medtech Companies
- With hospitals devoting nearly all their efforts to deal with the pandemic, elective procedures are being put on the backburner Continue reading...
- 04/29/2020
|
The Zacks Analyst Blog Highlights: Vapotherm, Inogen and Invacare
- The Zacks Analyst Blog Highlights: Vapotherm, Inogen and Invacare
- 04/29/2020
|
The Zacks Analyst Blog Highlights: Vapotherm, Inogen and Invacare
- The Zacks Analyst Blog Highlights: Vapotherm, Inogen and Invacare
- 04/29/2020
|
Inogen Inc (NASDAQ:INGN) Expected to Post Earnings of -$0.10 Per Share
- Wall Street brokerages expect Inogen Inc (NASDAQ:INGN) to announce earnings per share (EPS) of ($0.10) for the current fiscal quarter, according to Zacks Investment Research. Five analysts have issued estimates for Inogen’s earnings, with estimates ranging from ($0.12) to ($0.08). Inogen reported earnings of $0.24 per share during the same quarter last year, which would […]
- 04/29/2020
|
The Zacks Analyst Blog Highlights: Vapotherm, Inogen and Invacare
|
Analysts Estimate Inogen (INGN) to Report a Decline in Earnings: What to Look Out for
- Inogen (INGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/28/2020
|
Analysts Estimate Inogen (INGN) to Report a Decline in Earnings: What to Look Out for
- Inogen (INGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/28/2020
|
Here's Why You Should Retain Inogen (INGN) Stock for Now
- Investor confidence is high on Inogen (INGN) stock, thanks to solid prospects.
- 04/28/2020
|
Here's Why You Should Retain Inogen (INGN) Stock for Now
- Investor confidence is high on Inogen (INGN) stock, thanks to solid prospects.
- 04/28/2020
|
3 Stocks in Focus as Coronavirus Boosts Medical Oxygen Demand
- Oxygen therapy has emerged as a necessity for COVID-19 patients.
- 04/28/2020
|
3 Stocks in Focus as Coronavirus Boosts Medical Oxygen Demand
- Oxygen therapy has emerged as a necessity for COVID-19 patients.
- 04/28/2020
|
$83.35 Million in Sales Expected for Inogen Inc (NASDAQ:INGN) This Quarter
- Wall Street brokerages expect that Inogen Inc (NASDAQ:INGN) will report $83.35 million in sales for the current quarter, Zacks reports. Five analysts have issued estimates for Inogen’s earnings. The lowest sales estimate is $81.08 million and the highest is $88.90 million. Inogen reported sales of $90.20 million in the same quarter last year, which indicates […]
- 04/28/2020
|
Analysts Estimate Inogen (INGN) to Report a Decline in Earnings: What to Look Out for
|
Matarin Capital Management, LLC Buys Renewable Energy Group Inc, AMN Healthcare Services Inc, ...
|
Short Interest in Inogen Inc (NASDAQ:INGN) Drops By 6.6%
- Inogen Inc (NASDAQ:INGN) was the target of a significant decrease in short interest in March. As of March 31st, there was short interest totalling 2,120,000 shares, a decrease of 6.6% from the March 15th total of 2,270,900 shares. Approximately 11.6% of the company’s stock are short sold. Based on an average trading volume of 455,600 […]
- 04/23/2020
|
Inogen to Announce First Quarter 2020 Financial Results on Tuesday, May 5, 2020
- Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release first quarter 2020 financial results after market close on Tuesday, May 5, 2020. The Company will host a corresponding conference call beginning at 1:30pm PT/4:30pm ET.
- 04/21/2020
|
Louisiana State Employees Retirement System Has $259,000 Holdings in Inogen Inc (NASDAQ:INGN)
- Louisiana State Employees Retirement System cut its stake in shares of Inogen Inc (NASDAQ:INGN) by 19.3% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,010 shares of the medical technology company’s stock after selling 1,200 shares during the period. […]
- 04/21/2020
|
Curbstone Financial Management Corp Decreases Stock Position in Inogen Inc (NASDAQ:INGN)
- Curbstone Financial Management Corp lowered its stake in Inogen Inc (NASDAQ:INGN) by 4.2% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 11,322 shares of the medical technology company’s stock after selling 500 shares during the quarter. Curbstone Financial Management Corp […]
- 04/21/2020
|
Cardinal Capital Management Increases Position in Inogen Inc (NASDAQ:INGN)
- Cardinal Capital Management lifted its position in shares of Inogen Inc (NASDAQ:INGN) by 18.0% during the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 13,338 shares of the medical technology company’s stock after buying an additional 2,034 shares during the quarter. Cardinal Capital Management owned […]
- 04/21/2020
|
Is Inogen, Inc.’s (NASDAQ:INGN) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
- Most readers would already be aware that Inogen's (NASDAQ:INGN) stock increased significantly by 23% over the past...
- 04/20/2020
|
Bank of America Corp DE Sells 7,418 Shares of Inogen Inc (NASDAQ:INGN)
- Bank of America Corp DE lowered its position in Inogen Inc (NASDAQ:INGN) by 17.0% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 36,270 shares of the medical technology company’s stock after selling 7,418 shares during the quarter. Bank of America Corp DE owned about […]
- 04/19/2020
|
Inogen (NASDAQ:INGN) Lowered to Strong Sell at BidaskClub
- Inogen (NASDAQ:INGN) was downgraded by equities researchers at BidaskClub from a “sell” rating to a “strong sell” rating in a note issued to investors on Friday, BidAskClub reports. INGN has been the topic of a number of other reports. JPMorgan Chase & Co. lowered their target price on shares of Inogen from $60.00 to $45.00 […]
- 04/17/2020
|
A Rising Share Price Has Us Looking Closely At Inogen, Inc.'s (NASDAQ:INGN) P/E Ratio
- Inogen (NASDAQ:INGN) shares have had a really impressive month, gaining 31%, after some slippage. But shareholders may...
- 04/16/2020
|
Inogen (NASDAQ:INGN) Lowered to Hold at ValuEngine
- Inogen (NASDAQ:INGN) was downgraded by ValuEngine from a “buy” rating to a “hold” rating in a note issued to investors on Tuesday, ValuEngine reports. A number of other equities research analysts have also issued reports on the stock. Zacks Investment Research upgraded shares of Inogen from a “sell” rating to a “hold” rating and set […]
- 04/16/2020
|
Alliancebernstein L.P. Purchases 250 Shares of Inogen Inc (NASDAQ:INGN)
- Alliancebernstein L.P. lifted its position in shares of Inogen Inc (NASDAQ:INGN) by 0.9% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 29,247 shares of the medical technology company’s stock after purchasing an additional 250 shares during the quarter. Alliancebernstein L.P. owned about 0.13% […]
- 04/16/2020
|
Inogen, Inc. Announces Change of Date, Time and Location of 2020 Annual Meeting of Stockholders to Virtual-Only Annual Meeting
- Inogen, Inc. (NASDAQ: INGN) announced today that due to the public health impact of the coronavirus (COVID-19) pandemic, and to support the health and well-being of its employees, stockholders, and other meeting participants, the company has changed the date, time and format of its 2020 Annual Meeting of Stockholders ("Annual Meeting"). The Annual Meeting will now be held at 9:00 a.m. Pacific time on Monday, May 11, 2020 by means of a virtual meeting format only instead of the date, time and location previously disclosed in Inogen’s proxy materials filed with the Securities and Exchange Commission on March 24, 2020.
- 04/14/2020
|
Inogen Shows Market Leadership With Jump To 83 RS Rating
|
Man Group plc Invests $222,000 in Inogen Inc (NASDAQ:INGN)
- Man Group plc acquired a new position in shares of Inogen Inc (NASDAQ:INGN) during the fourth quarter, Holdings Channel reports. The fund acquired 3,255 shares of the medical technology company’s stock, valued at approximately $222,000. A number of other hedge funds and other institutional investors have also made changes to their positions in INGN. State […]
- 04/13/2020
|
UBS Group AG Trims Stake in Inogen Inc (NASDAQ:INGN)
- UBS Group AG trimmed its holdings in Inogen Inc (NASDAQ:INGN) by 10.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 27,183 shares of the medical technology company’s stock after selling 3,334 shares during the quarter. UBS Group AG owned approximately 0.12% of […]
- 04/12/2020
|
Have Insiders Been Buying Inogen, Inc. (NASDAQ:INGN) Shares?
- We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly...
- 04/10/2020
|
A Rising Share Price Has Us Looking Closely At Inogen, Inc.’s (NASDAQ:INGN) P/E Ratio
- Inogen (NASDAQ:INGN) shareholders are no doubt pleased to see that the share price has bounced 32% in the last month...
- 04/10/2020
|
Patent Filings Roundup: Fertilizer, Fitness Tracker and Phone Fights
- District court patent filings are up again this week, demonstrating that even a good lockdown can’t keep patent lawyers down; indeed, it appears there’s no sleep for the weary, given the spike in NPE assertions and a fair amount of medium-sized company-to-company litigation.
- 04/09/2020
|
Bank of New York Mellon Corp Purchases 4,063 Shares of Inogen Inc (NASDAQ:INGN)
- Bank of New York Mellon Corp grew its stake in shares of Inogen Inc (NASDAQ:INGN) by 2.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 211,418 shares of the medical technology company’s stock after purchasing an additional 4,063 shares during the period. […]
- 04/09/2020
|
Janus Henderson Group PLC Acquires 696 Shares of Inogen Inc (NASDAQ:INGN)
- Janus Henderson Group PLC increased its holdings in shares of Inogen Inc (NASDAQ:INGN) by 5.8% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 12,765 shares of the medical technology company’s stock after purchasing an additional 696 shares during the period. Janus Henderson Group PLC’s holdings in Inogen […]
- 04/08/2020
|
Cubist Systematic Strategies LLC Sells 87,000 Shares of Inogen Inc (NASDAQ:INGN)
- Cubist Systematic Strategies LLC decreased its position in Inogen Inc (NASDAQ:INGN) by 87.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,082 shares of the medical technology company’s stock after selling 87,000 shares during the quarter. Cubist Systematic […]
- 04/07/2020
|
Does Inogen, Inc.’s (NASDAQ:INGN) CEO Pay Reflect Performance?
- In 2017 Scott Wilkinson was appointed CEO of Inogen, Inc. (NASDAQ:INGN). First, this article will compare CEO...
- 04/06/2020
|
Inogen Inc (NASDAQ:INGN) Expected to Announce Earnings of -$0.10 Per Share
- Equities research analysts forecast that Inogen Inc (NASDAQ:INGN) will post ($0.10) earnings per share for the current fiscal quarter, according to Zacks Investment Research. Five analysts have provided estimates for Inogen’s earnings. The highest EPS estimate is ($0.08) and the lowest is ($0.12). Inogen reported earnings of $0.24 per share in the same quarter last […]
- 04/06/2020
|
Marshall Wace LLP Has $33,000 Stake in Inogen Inc (NASDAQ:INGN)
- Marshall Wace LLP trimmed its stake in Inogen Inc (NASDAQ:INGN) by 99.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 477 shares of the medical technology company’s stock after selling 63,486 shares during the period. Marshall Wace LLP’s holdings in Inogen were […]
- 04/06/2020
|
Inogen Inc (NASDAQ:INGN) Shares Acquired by Advisor Group Inc.
- Advisor Group Inc. increased its stake in Inogen Inc (NASDAQ:INGN) by 559.7% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 2,098 shares of the medical technology company’s stock after buying an additional 1,780 shares during the quarter. Advisor Group Inc.’s holdings in Inogen […]
- 04/02/2020
|
Amalgamated Bank Makes New $246,000 Investment in Inogen Inc (NASDAQ:INGN)
- Amalgamated Bank bought a new position in shares of Inogen Inc (NASDAQ:INGN) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 3,595 shares of the medical technology company’s stock, valued at approximately $246,000. Several other institutional investors have also recently […]
- 04/01/2020
|
5,416 Shares in Inogen Inc (NASDAQ:INGN) Purchased by Envestnet Asset Management Inc.
- Envestnet Asset Management Inc. acquired a new position in Inogen Inc (NASDAQ:INGN) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 5,416 shares of the medical technology company’s stock, valued at approximately $370,000. Other institutional investors also recently modified their holdings of the company. Tamarack […]
- 03/31/2020
|
Inogen (INGN) Up 9.7% Since Last Earnings Report: Can It Continue?
- Inogen (INGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- 03/26/2020
|
Inogen (INGN) Up 9.7% Since Last Earnings Report: Can It Continue?
- Inogen (INGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- 03/26/2020
|
Inogen (INGN) Up 9.7% Since Last Earnings Report: Can It Continue?
|
Here's Why You Should Hold On to Inogen (INGN) Stock for Now
- Inogen (INGN) expects to report a loss per share in the first quarter of 2020.
- 03/25/2020
|
Here's Why You Should Hold On to Inogen (INGN) Stock for Now
- Inogen (INGN) expects to report a loss per share in the first quarter of 2020.
- 03/25/2020
|
Inogen Inc (NASDAQ:INGN) Shares Sold by AQR Capital Management LLC
- AQR Capital Management LLC lessened its position in Inogen Inc (NASDAQ:INGN) by 30.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 862,602 shares of the medical technology company’s stock after selling 373,286 shares during the quarter. AQR Capital Management […]
- 03/24/2020
|
Inogen (NASDAQ:INGN) Upgraded at BidaskClub
- Inogen (NASDAQ:INGN) was upgraded by equities researchers at BidaskClub from a “strong sell” rating to a “sell” rating in a report issued on Tuesday, BidAskClub reports. Other equities research analysts have also recently issued research reports about the stock. Zacks Investment Research upgraded shares of Inogen from a “sell” rating to a “hold” rating and […]
- 03/24/2020
|
Inogen (NASDAQ:INGN) Upgraded to "Buy" by ValuEngine
- Inogen (NASDAQ:INGN) was upgraded by equities research analysts at ValuEngine from a “hold” rating to a “buy” rating in a report released on Tuesday, ValuEngine reports. Several other analysts have also recently commented on the stock. JPMorgan Chase & Co. reduced their target price on shares of Inogen from $60.00 to $45.00 and set an […]
- 03/24/2020
|
111 Biggest Movers From Yesterday
|
71 Stocks Moving In Monday's Mid-Day Session
- Gainers
Hoth Therapeutics, Inc (NASDAQ: HOTH) shares jumped 99% to $5.50 after the company reported a deal to jointly develop self-assembling vaccine for potential coronavirus...
- 03/23/2020
|
Inogen (INGN) Receives a Buy from Needham
- In a report released today, Michael Matson from Needham maintained a Buy rating on Inogen (INGN), with a price target of $80.00. The company's shares
- 03/23/2020
|
Inogen (INGN) Receives a Buy from Needham
- In a report released today, Michael Matson from Needham maintained a Buy rating on Inogen (INGN – Research Report), with
- 03/23/2020
|
A Look At The Fair Value Of Inogen, Inc. (NASDAQ:INGN)
- Today we will run through one way of estimating the intrinsic value of Inogen, Inc. (NASDAQ:INGN) by taking the...
- 03/23/2020
|
AlphaCrest Capital Management LLC Sells 14,641 Shares of Inogen Inc (NASDAQ:INGN)
- AlphaCrest Capital Management LLC reduced its holdings in shares of Inogen Inc (NASDAQ:INGN) by 74.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 5,059 shares of the medical technology company’s stock after selling 14,641 shares during the quarter. AlphaCrest […]
- 03/21/2020
|
Great West Life Assurance Co. Can Makes New Investment in Inogen Inc (NASDAQ:INGN)
- Great West Life Assurance Co. Can acquired a new position in Inogen Inc (NASDAQ:INGN) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 23,542 shares of the medical technology company’s stock, valued at approximately $1,596,000. Great West Life Assurance Co. Can owned […]
- 03/20/2020
|
Jefferies Group LLC Makes New Investment in Inogen Inc (NASDAQ:INGN)
- Jefferies Group LLC bought a new position in shares of Inogen Inc (NASDAQ:INGN) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 6,560 shares of the medical technology company’s stock, valued at approximately $448,000. Several other hedge funds have also recently […]
- 03/20/2020
|
Bank of Montreal Can Increases Holdings in Inogen Inc (NASDAQ:INGN)
- Bank of Montreal Can lifted its holdings in Inogen Inc (NASDAQ:INGN) by 31.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,650 shares of the medical technology company’s stock after acquiring an additional 1,100 shares during the period. Bank of Montreal […]
- 03/20/2020
|
IntriCon appoints Heather Rider to board of directors IIN;INGN
- IntriCon appoints Heather Rider to board of directors IIN INGN
- 03/19/2020
|
IntriCon Appoints Heather Rider to its Board of Directors
- IntriCon Corporation (IIN), a designer, developer and manufacturer of miniature interventional, implantable and body-worn medical devices, today announced the appointment of Heather Rider to the company’s Board of Directors, effective March 20, 2020. “I am delighted to welcome Heather to our board of
- 03/19/2020
|
Homecare Oxygen Concentrators Market to hit USD 1700 Million by 2026: Global Market Insights, Inc.
- Selbyville, Delaware, March 19, 2020 -- According to latest report “Homecare Oxygen Concentrators Market by Product (Portable Home Oxygen Concentrators {Stationary,.
- 03/19/2020
|
Did You Manage To Avoid Inogen's (NASDAQ:INGN) Painful 60% Share Price Drop?
- Even the best stock pickers will make plenty of bad investments. And there's no doubt that Inogen, Inc. (NASDAQ:INGN...
- 03/18/2020
|
Inogen (NASDAQ:INGN) Rating Increased to Hold at Zacks Investment Research
- Inogen (NASDAQ:INGN) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Monday, Zacks.com reports. The firm presently has a $46.00 price objective on the medical technology company’s stock. Zacks Investment Research‘s price objective suggests a potential upside of 21.98% from the stock’s current price. According […]
- 03/18/2020
|
Inogen Inc (NASDAQ:INGN) Shares Sold by Blair William & Co. IL
- Blair William & Co. IL trimmed its position in Inogen Inc (NASDAQ:INGN) by 1.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 110,568 shares of the medical technology company’s stock after selling 1,903 shares during the period. Blair William & […]
- 03/14/2020
|
Inogen Inc (NASDAQ:INGN) Given Consensus Rating of "Hold" by Brokerages
- Shares of Inogen Inc (NASDAQ:INGN) have received a consensus recommendation of “Hold” from the eight research firms that are currently covering the stock, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, four have issued a hold rating and two have assigned a buy rating to the company. The […]
- 03/12/2020
|
Charles Schwab Investment Management Inc. Purchases 1,884 Shares of Inogen Inc (NASDAQ:INGN)
- Charles Schwab Investment Management Inc. boosted its position in Inogen Inc (NASDAQ:INGN) by 1.7% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 111,811 shares of the medical technology company’s stock after acquiring an additional 1,884 shares during the period. Charles Schwab […]
- 03/11/2020
|
What Does Inogen, Inc.’s (NASDAQ:INGN) Share Price Indicate?
- Inogen, Inc. (NASDAQ:INGN), which is in the medical equipment business, and is based in United States, received a lot...
- 03/10/2020
|
Edited Transcript of INGN earnings conference call or presentation 25-Feb-20 9:30pm GMT
- Q4 2019 Inogen Inc Earnings Call
- 03/09/2020
|
Edited Transcript of INGN earnings conference call or presentation 25-Feb-20 9:30pm GMT
- Q4 2019 Inogen Inc Earnings Call
- 03/08/2020
|
Svb Leerink Analysts Reduce Earnings Estimates for Inogen Inc (NASDAQ:INGN)
- Inogen Inc (NASDAQ:INGN) – Stock analysts at Svb Leerink decreased their Q1 2020 earnings per share (EPS) estimates for Inogen in a note issued to investors on Wednesday, February 26th. Svb Leerink analyst D. Antalffy now forecasts that the medical technology company will post earnings per share of ($0.12) for the quarter, down from their […]
- 03/02/2020
|
KeyCorp Comments on Inogen Inc's Q2 2020 Earnings (NASDAQ:INGN)
- Inogen Inc (NASDAQ:INGN) – KeyCorp issued their Q2 2020 earnings estimates for shares of Inogen in a report released on Tuesday, February 25th. KeyCorp analyst M. Mishan expects that the medical technology company will post earnings of $0.35 per share for the quarter. KeyCorp also issued estimates for Inogen’s Q3 2020 earnings at $0.37 EPS […]
- 02/29/2020
|
Q2 2020 Earnings Forecast for Inogen Inc Issued By Svb Leerink (NASDAQ:INGN)
- Inogen Inc (NASDAQ:INGN) – Svb Leerink cut their Q2 2020 earnings per share estimates for shares of Inogen in a report issued on Wednesday, February 26th. Svb Leerink analyst D. Antalffy now anticipates that the medical technology company will post earnings per share of $0.32 for the quarter, down from their previous forecast of $0.38. […]
- 02/29/2020
|
Research Analysts Offer Predictions for Inogen Inc's Q1 2020 Earnings (NASDAQ:INGN)
- Inogen Inc (NASDAQ:INGN) – KeyCorp issued their Q1 2020 EPS estimates for Inogen in a report issued on Tuesday, February 25th. KeyCorp analyst M. Mishan anticipates that the medical technology company will post earnings per share of ($0.11) for the quarter. KeyCorp also issued estimates for Inogen’s Q4 2020 earnings at $0.09 EPS and FY2020 […]
- 02/28/2020
|
Inogen, Inc. Just Missed EPS By 13%: Here's What Analysts Think Will Happen Next
- It's been a good week for Inogen, Inc. (NASDAQ:INGN) shareholders, because the company has just released its latest...
- 02/27/2020
|
Inogen, Inc. Just Missed Earnings And Its EPS Looked Sad – But Analysts Have Updated Their Models
- It's been a good week for Inogen, Inc. (NASDAQ:INGN) shareholders, because the company has just released its latest...
- 02/27/2020
|
Inogen (NASDAQ:INGN) Hits New 12-Month Low After Earnings Miss
- Inogen Inc (NASDAQ:INGN)’s share price reached a new 52-week low during mid-day trading on Wednesday following a weaker than expected earnings announcement. The company traded as low as $37.25 and last traded at $46.99, with a volume of 247173 shares. The stock had previously closed at $41.98. The medical technology company reported ($0.06) EPS for […]
- 02/27/2020
|
95 Biggest Movers From Yesterday
|
2020 Respiratory Assist Devices Medical Devices - Pipeline Assessment - ResearchAndMarkets.com
- The "Respiratory Assist Devices - Medical Devices Pipeline Assessment, 2020" report has been added to ResearchAndMarkets.com's offering.
- 02/26/2020
|
Inogen (INGN) Receives a Sell from J.P. Morgan
- J.P. Morgan analyst Robbie Marcus maintained a Sell rating on Inogen (INGN) today and set a price target of $45.00. The company's shares closed last
- 02/26/2020
|
Inogen (INGN) Receives a Sell from J.P. Morgan
- J.P. Morgan analyst Robbie Marcus maintained a Sell rating on Inogen (INGN – Research Report) today and set a price
- 02/26/2020
|
Inogen's (INGN) Q4 Earnings Miss, Revenues Top Estimates
- Inogen (INGN) sees segmental softness in the fourth quarter.
- 02/26/2020
|
Inogen's (INGN) Q4 Earnings Miss, Revenues Top Estimates
- Inogen (INGN) sees segmental softness in the fourth quarter.
- 02/26/2020
|
American International Group Inc. Sells 35,189 Shares of Inogen Inc (NASDAQ:INGN)
- American International Group Inc. cut its stake in Inogen Inc (NASDAQ:INGN) by 72.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 13,191 shares of the medical technology company’s stock after selling 35,189 shares during the quarter. American International Group Inc.’s […]
- 02/26/2020
|
Inogen Inc (INGN) Q4 2019 Earnings Call Transcript
- INGN earnings call for the period ending December 31, 2019.
- 02/26/2020
|
Inogen, Inc. (INGN) CEO Scott Wilkinson on Q4 2019 Results - Earnings Call Transcript
- Inogen, Inc. (NASDAQ:INGN) Q4 2019 Earnings Conference Call February 25, 2020 04:30 PM ET Company Participants Matt Bacso - IR Scott Wilkinson - CEO Ali Bauerle
- 02/26/2020
|
JP Morgan Maintains Underweight on Inogen, Lowers Price Target to $45
|
Inogen (INGN) Q4 Earnings Miss Estimates
- Inogen (INGN) delivered earnings and revenue surprises of -36.36% and 0.02%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
- 02/25/2020
|
Inogen (INGN) Q4 Earnings Miss Estimates
- Inogen (INGN) delivered earnings and revenue surprises of -36.36% and 0.02%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
- 02/25/2020
|
Inogen: 4Q Earnings Snapshot
- GOLETA, Calif. (AP) _ Inogen Inc. (INGN) on Tuesday reported a fourth-quarter loss of $1.4 million, after reporting a profit in the same period a year earlier. The Goleta, California-based company said it had a loss of 6 cents per share. Earnings, adjusted for amortization costs and non-recurring costs, were 7 cents per share. The results missed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 11 cents per share. The produces oxygen concentrators for patients suffering from chronic respiratory conditions posted revenue of $78.9 million in the period. For the year, the company reported profit of $21 million, or 94 cents per share. Revenue was reported as $361.9 million. Inogen expects full-year revenue in the range of $385 million to $400 million. Inogen shares have declined 39% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $41.98, a drop of 71% in the last 12 months. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on INGN at https://www.zacks.com/ap/INGN
- 02/25/2020
|
Inogen: 4Q Earnings Snapshot
- GOLETA, Calif. (AP) _ Inogen Inc. (INGN) on Tuesday reported a fourth-quarter loss of $1.4 million, after reporting a profit in the same period a year earlier. The Goleta, California-based company said it had a loss of 6 cents per share. The average estimate of four analysts surveyed by Zacks Investment
- 02/25/2020
|
Inogen Announces Fourth Quarter and Full Year 2019 Financial Results and Updates 2020 Guidance
- Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three-month and twelve-month periods ended December 31, 2019.
- 02/25/2020
|
Inogen Reaffirms FY20 Sales Guidance $385M-$400M
|
Inogen Q4 2019 Earnings Preview
- Inogen (NASDAQ:INGN) is scheduled to announce Q4 earnings results on Tuesday, February 25th, after market close.The consensus EPS Estimate is $0.09 (-79.5% Y/Y) and the consensus Revenue Estimate is $
- 02/24/2020
|
Is Inogen, Inc. (NASDAQ:INGN) A Volatile Stock?
- If you own shares in Inogen, Inc. (NASDAQ:INGN) then it's worth thinking about how it contributes to the volatility of...
- 02/24/2020
|
Does Inogen, Inc. (NASDAQ:INGN) Have A Particularly Volatile Share Price?
- If you're interested in Inogen, Inc. (NASDAQ:INGN), then you might want to consider its beta (a measure of share price...
- 02/24/2020
|
Inogen (INGN) Set to Announce Quarterly Earnings on Tuesday
- Inogen (NASDAQ:INGN) is set to announce its earnings results after the market closes on Tuesday, February 25th. Analysts expect the company to announce earnings of $0.11 per share for the quarter. Investors interested in participating in the company’s conference call can do so using this link. Inogen stock opened at $44.13 on Monday. The company […]
- 02/24/2020
|
Rockefeller Capital Management L.P. Raises Stock Holdings in Inogen Inc (NASDAQ:INGN)
- Rockefeller Capital Management L.P. boosted its holdings in shares of Inogen Inc (NASDAQ:INGN) by 0.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 281,027 shares of the medical technology company’s stock after purchasing an additional 2,427 shares during the quarter. Rockefeller Capital Management […]
- 02/21/2020
|
Respiratory Assist Devices Pipeline Assessment, 2020
- Dublin, Feb. 21, 2020 -- The "Respiratory Assist Devices - Medical Devices Pipeline Assessment, 2020" report has been added to ResearchAndMarkets.com's offering..
- 02/21/2020
|
2020 Study on Respiratory Assist Devices Currently in the Pipeline - Product Profiles, Clinical Trials, Key Players and More
- The "Respiratory Assist Devices - Medical Devices Pipeline Assessment, 2020" report has been added to ResearchAndMarkets.com's offering.
- 02/20/2020
|
Moving Average Crossover Alert: Inogen
- Inogen, Inc. (INGN) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.
- 02/18/2020
|
Moving Average Crossover Alert: Inogen
- Inogen, Inc. (INGN) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.
- 02/18/2020
|
Moving Average Crossover Alert: Inogen
|
